Prudence M. Grandison

654 total citations
11 papers, 545 citations indexed

About

Prudence M. Grandison is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Prudence M. Grandison has authored 11 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Prudence M. Grandison's work include Toxin Mechanisms and Immunotoxins (5 papers), Galectins and Cancer Biology (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Prudence M. Grandison is often cited by papers focused on Toxin Mechanisms and Immunotoxins (5 papers), Galectins and Cancer Biology (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Prudence M. Grandison collaborates with scholars based in New Zealand, France and China. Prudence M. Grandison's co-authors include Nagarajan Kannan, Peter E. Lobie, Jo K. Perry, Megan C. McDonald, James D. Watson, Matthew A. Sleeman, J. Greg Murison, Krishnanand D. Kumble, Murray D. Mitchell and Ross L. Prestidge and has published in prestigious journals such as Endocrinology, Infection and Immunity and Gene.

In The Last Decade

Prudence M. Grandison

11 papers receiving 531 citations

Peers

Countries citing papers authored by Prudence M. Grandison

Since Specialization

Citations

This map shows the geographic impact of Prudence M. Grandison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence M. Grandison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence M. Grandison more than expected).

Fields of papers citing papers by Prudence M. Grandison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prudence M. Grandison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence M. Grandison. The network helps show where Prudence M. Grandison may publish in the future.

Co-authorship network of co-authors of Prudence M. Grandison

This figure shows the co-authorship network connecting the top 25 collaborators of Prudence M. Grandison. A scholar is included among the top collaborators of Prudence M. Grandison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prudence M. Grandison. Prudence M. Grandison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma 2010 ·Neoplasia ·Nagarajan Kannan, Jian Kang, Xiangjun Kong, Jian‐Zhong Tang, Jo K. Perry, Kumarasamypet M. Mohankumar, Lance D. Miller, Edison T. Liu, Hichem C. Mertani, Tao Zhu, Prudence M. Grandison, Dongxu Liu, Peter E. Lobie	63
2	Trefoil Factor-1 (TFF1) Enhances Oncogenicity of Mammary Carcinoma Cells 2009 ·Endocrinology ·(unknown), Xiangjun Kong, Nethaji Muniraj, Nagarajan Kannan, Prudence M. Grandison, Juan Lin, Yulu Yang, (unknown), Sahra Borgés, Jo K. Perry, Hichem C. Mertani, Tao Zhu, Dongxu Liu, Peter E. Lobie	57
3	Are trefoil factors oncogenic? 2007 ·Trends in Endocrinology and Metabolism ·Jo K. Perry, Nagarajan Kannan, Prudence M. Grandison, Murray D. Mitchell, Peter E. Lobie	95
4	Identification of a new fibroblast growth factor receptor, FGFR5 2001 ·Gene ·Matthew A. Sleeman, (unknown), Megan C. McDonald, (unknown), (unknown), Prudence M. Grandison, Krishnanand D. Kumble, James D. Watson, J. Greg Murison	215
5	Silencer and Enhancer Regions in the Human CD95 (Fas/APO-1) Gene with Sequence Similarity to the Granulocyte-Macrophage Colony-Stimulating Factor Promoter: Binding of Single Strand-Specific Silencer Factors and AP-1 and NF-AT-Like Enhancer Factors 1998 ·DNA and Cell Biology ·Fritz Rudert, (unknown), Annette Lasham, Yue Wang, Prudence M. Grandison, James Watson	8
6	pLEF, a novel vector for expression of glutathione S-transferase fusion proteins in mammalian cells 1996 ·Gene ·Fritz Rudert, Elizabeth Visser, Gabriele Gradl, Prudence M. Grandison, Lirim Shemshedini, Yue Wang, (unknown), James Watson	25
7	The CD95 (Fas/APO-1) receptor is phosphorylatedin vitro andin vivo and constitutively associates with several cellular proteins 1996 ·APOPTOSIS ·Gabriele Gradl, Prudence M. Grandison, (unknown), (unknown), James Watson, Fritz Rudert	13
8	Production of the 19-kDa antigen of Mycobacterium tuberculosis in Escherichia coli and its purification 1995 ·Gene ·Ross L. Prestidge, Prudence M. Grandison, (unknown), Roger J. Booth, (unknown)	6
9	Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19-kilodalton antigens in other mycobacteria 1993 ·Infection and Immunity ·R J Booth, Diana L. Williams, Kamal D. Moudgil, (unknown), Prudence M. Grandison, (unknown), Ross L. Prestidge, J D Watson	57
10	The use of a ‘universal’ yeast expression vector to produce an antigenic protein of Mycobacterium leprae 1988 ·Immunology Letters ·Roger J. Booth, Prudence M. Grandison, Ross L. Prestidge, (unknown)	5
11	The degradation of bovine parathyroid hormone by leukocytes 1987 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Peter M. Barling, (unknown), (unknown), Prudence M. Grandison, G. Kenneth Scott	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact